Effect of Pneumoperitoneum on the Continuous and Non-invasive Hemoglobin Monitoring

Effect of Pneumoperitoneum on the Continuous and Non-invasive Hemoglobin Monitoring for Laparoscopic Gastrectomy: a Randomized Controlled Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03430778

Enrollment

Registered

2018-02-13

Start date

2019-01-01

Completion date

2019-05-13

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The primary purpose of this study is to investigate the effect of pneumoperitoneum on the continuous and non-invasive hemoglobin monitoring during laparoscopic gastrectomy

Interventions

OTHERHigh end-tidal CO2

maintaining of end-tidal CO2 with the range of 40-45 mmHg

OTHERLow CO2 group

maintaining of end-tidal CO2 with the range of 30-35 mmHg

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

19 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Laparoscopic gastrectomy under general anesthesia

Exclusion criteria

* atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease

Design outcomes

Primary

Measure	Time frame	Description
difference between SpHb value and SaHb value (SpHb - SaHb)	from the start of anesthesia to the end of anesthesia, an average 2 hours	SpHb value is measured by co-oxymetry, and SaHb value is measured by blood sampling.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026